Literature DB >> 3403621

Circulating vitamin K levels in patients with fractures.

L Bitensky1, J P Hart, A Catterall, S J Hodges, M J Pilkington, J Chayen.   

Abstract

It is now clear that vitamin K1 is part of a biochemical cycle that is essential for the conversion of specific bone peptides into a form that can bind calcium. We have used a recently described procedure for assaying vitamin K1 in plasma to test the involvement of this vitamin in fracture healing. Markedly depressed circulating levels were found in patients with fractures and the time taken for this level to return to normal appeared to be influenced by the severity of the fracture.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3403621

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  4 in total

Review 1.  Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies.

Authors:  John A Batsis; Dennis T Villareal
Journal:  Nat Rev Endocrinol       Date:  2018-09       Impact factor: 43.330

2.  Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules.

Authors:  Tetsuo Inoue; Toshiharu Fujita; Hideaki Kishimoto; Toshitaka Makino; Tetsuro Nakamura; Toshitaka Nakamura; Tosiya Sato; Kaoru Yamazaki
Journal:  J Bone Miner Metab       Date:  2008-12-12       Impact factor: 2.626

3.  Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women.

Authors:  Naoko Tsugawa; Masataka Shiraki; Yoshitomo Suhara; Maya Kamao; Reo Ozaki; Kiyoshi Tanaka; Toshio Okano
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

4.  Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial.

Authors:  Angela M Cheung; Lianne Tile; Yuna Lee; George Tomlinson; Gillian Hawker; Judy Scher; Hanxian Hu; Reinhold Vieth; Lilian Thompson; Sophie Jamal; Robert Josse
Journal:  PLoS Med       Date:  2008-10-14       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.